NExT exam evaluation criteria must be moderate, allocate ample time for preparation, release schedule early: Parliamentary panel tells Health Ministry
New Delhi: After the recent suggestion from the Indian Medical Association (IMA) to reconsider the implementation of the National Exit Test (NExT) exam, a parliamentary committee has recommended to the Union Ministry of Health and Family Welfare to thoroughly examine the implications of NExT exam, which will serve as a common qualifying final-year MBBS exam, a licentiate exam to practise modern medicine and also as the gateway to get admission to postgraduate medical courses.
Besides, the Parliamentary panel has also advocated for due diligence in addressing the concerns of all the relevant stakeholders, reports PTI. The committee recommended that the government allocate ample time for thorough preparation and provide an early release of the exam schedule, along with other relevant details regarding the examination.
This will enable the first batch of candidates to prepare adequately and smoothly transition to the new examination format. Additionally, considering the diverse background of medical colleges from which the first batch of NExT aspirants would come, the committee suggested that the evaluation criteria should be moderate.
In its report, which was tabled in the Parliament this week, the panel mentioned, "It is imperative to ensure that no group of graduates faces an undue advantage or disadvantage in the examination. Striking a fair and equitable balance in the evaluation process will be pivotal in ensuring the success and fairness of the NExT exam."
The panel noted that the assessment of medical graduates would ensure that all medical graduates have a uniform level of knowledge and skills, regardless of where they studied.
"This improves the quality of medical education and training in India and makes the process of licensure and postgraduate admissions more transparent and fairer," said the panel.
The issue of the NExT exam has been making waves in the medical fraternity ever since its first announcement. Although last year NMC released the NExT regulations and announced conducting the exam for the 2019 MBBS batch, it was ultimately put on hold for an indefinite time.
Thereafter, the Union Health Ministry has constituted a seven-member committee to look into the preparedness of States and medical colleges for the implementation of the exam for the final year MBBS students of the 2020 batch.
Amidst the debate and uncertainty regarding the conduct of NExT exam, NMC made the issue open to all the stakeholders. Recently, issuing a notice, NCM asked the stakeholders to submit their feedback on the NMC National Exit Test Regulations, 2023 by 07.02.2024. The deadline was further extended by the Commission till 17.02.2024.
Also Read: Reconsider implementation of National Exit Test: IMA to NMC
Meanwhile, recently, submitting its feedback on the NEXT examination, the Indian Medical Association (IMA) has opposed the Commission's plans for conducting the exam as it opined that since the standards of medical education across all academic institutions vary, testing the entire country with one test would not be "feasible".
In a letter addressed to the Chairman of NMC, Dr B.N.Gangadhar, the association highlighted that the medical colleges across the country are facing inadequate technical infrastructure, and faculty training and support. Therefore, IMA stated that NMC should not proceed with NExT until these prerequisites are duly satisfied.
Now, a parliamentary committee has also recommended to the Union Health Ministry to thoroughly examine the implications of NExT Exam and advocated for due diligence in addressing the concerns of all the relevant stakeholders.
Further, the panel stated that in addition to standardised final assessment of graduates, there is an urgent need to universalize or standardise undergraduate and postgraduate education.
Reputed institutes like AIIMS impart different quality of medical education while newly opened medical institutes need such quality.
Keeping this in view, it recommended the government to divide India into zones, and in each zone reputed institutes like AIIMS can function as mentor institutes for all the other medical colleges in that zone.
Mentor institutes shall play a significant role in monitoring the standard of education and the classes in the newly set medical colleges or private medical colleges, it said.
The committee further recommended that the National Medical Commission (NMC) should address the inconsistencies in granting permanent registration to foreign medical graduates across various states.
The FMG Regulations 2021 are a pivotal framework to maintain and uphold the quality of medical professionals in India.
"However, these regulations must adopt a facilitative role rather than imposing unwarranted obstacles in the registration and internship process for foreign medical graduates," it observed.
The panel recommended the NMC to strike a balance between quality assurance and inclusivity, ensuring that bureaucratic or procedural impediments do not unduly burden foreign medical graduates who meet the necessary standards.
By acting as facilitators, regulatory authorities can streamline the registration and internship procedures, enhancing the integration of foreign medical graduates into the Indian healthcare system, it said in the report.
Further to address the issue of ghost faculty and ensure that the available faculty comes to the college to teach, the committee recommended to the government to strictly enforce the regulations already in place to curb the problem of ghost faculty and zero attendance.
The NMC should conduct regular inspections of medical colleges and take action against colleges that are found to be violating the regulations, it stressed.
Also Read: NMC Extends Deadline for Submitting Comments on National Exit Test Regulations 2023
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd